Sustained release of a corticosteroid using polymeric implants.
An effective sustained release method of drug administration, using methylprednisolone incorporated into acrylic bone cement, has been developed. The effect of this form of treatment on peripheral blood leukocytes, lymphoid tissue weight and the inflammatory response has been evaluated. This mode of methylprednisolone administration was compared with conventional systemic therapy and was found to produce rapid and prolonged pharmacological effects at very low plasma levels of drug. A dose response relationship was established and we determined that, for a given quantity of drug, the level and duration of suppression was greater using sustained release therapy. The inflammatory response was also depressed using this mode of administration. These results, coupled with the commercial availability and existing clinical approval of SIMPLEX P bone cement, suggest that further development may lead to useful clinical protocols.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000097:blood; D000818:Animals; D001843:Bone Cements; D002851:Chromatography, High Pressure Liquid; D004343:Drug Implants; D004487:Edema / Q000378:metabolism; D005260:Female; D007700:Kinetics; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008775:Methylprednisolone / Q000032:analysis; D009504:Neutrophils / Q000187:drug effects; D011108:Polymers; D051381:Rats
D000305:Adrenal Cortex Hormones; D001843:Bone Cements; D004343:Drug Implants; D011108:Polymers; D008775:Methylprednisolone